Business Context and Reporting Period
This Form 8-K Current Report was filed by Genpact Limited on July 16, 2021, with the earliest event reported on the same date. The filing discloses the appointment of a new Chief Financial Officer (CFO) and the departure of the incumbent CFO, effective August 10, 2021.
Key Financial Metrics
The filing does not contain operational financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on executive compensation and employment terms.
- Base Salary (New CFO): $600,000 annually.
- Target Bonus (New CFO): 100% of base salary ($600,000).
- Initial Option Grant Value: $4,000,000 (Black Scholes value).
- Initial Performance Share Grant Value: $1,000,000 (target).
- Initial RSU Grant Value: $2,000,000.
Material Changes
The primary material change is the leadership transition in the finance function:
- Appointment: Michael Weiner will become Chief Financial Officer, effective August 10, 2021.
- Departure: Edward Fitzpatrick will step down as CFO and transition to the role of Senior Vice President and Senior Client Advisor, reporting to the CEO.
- Employment Agreement: An agreement was entered into on July 16, 2021, effective August 2, 2021, detailing Mr. Weiner's compensation and severance terms.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or management commentary regarding business performance. It does disclose specific contractual risks and contingencies related to executive compensation:
- Severance Terms: In the event of termination without "cause" or resignation for "good reason," Mr. Weiner is eligible for 12 months of base salary, a pro-rated target bonus, and 18 months of health benefits.
- Change of Control: Accelerated vesting of equity awards applies if termination occurs within 24 months of a change of control. If termination occurs outside this window but within 24 months of a change of control, awards vest in full.
- Golden Parachute: The agreement includes a Section 280G "best pay" provision to maximize after-tax benefits if excise taxes apply.
- Conditions: Severance payments are conditioned on the execution of a general release of claims and compliance with non-compete and confidentiality covenants.
Investor Verification Checklist
- Verify the exact closing price of Genpact common shares on the grant date (August 10, 2021) to calculate the specific number of shares in the option, performance share, and RSU grants.
- Review the full text of the Employment Agreement (Exhibit 10.1) and equity award forms (Exhibits 10.2, 10.3, 10.4) for specific definitions of "cause," "good reason," and "change of control."
- Confirm the transition timeline for Mr. Fitzpatrick's new role as SVP and Senior Client Advisor.
- Assess the impact of the new CFO's background (formerly National General Holdings Corp./Allstate) on Genpact's strategic direction.